Cardiovascular benefits of paricalcitol in chronic kidney disease

被引：0
|
作者：
Jessica K. Edwards
机构：
来源：
Nature Reviews Nephrology | 2014年 / 10卷 / 12期
关键词：
D O I：
10.1038/nrneph.2014.200
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：675 / 675
相关论文
共 50 条
  • [41] Cardiovascular Disease in Children with Chronic Kidney Disease
    Mitsnefes, Mark M.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (04): : 578 - 585
  • [42] Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease
    Nicholas J. A. Webb
    Gary Lerner
    Bradley A. Warady
    Katherine M. Dell
    Larry A. Greenbaum
    Gema Ariceta
    Bernd Hoppe
    Peter Linde
    Ho-Jin Lee
    Ann Eldred
    Matthew B. Dufek
    Pediatric Nephrology, 2017, 32 : 1221 - 1232
  • [43] Paricalcitol Reduces Proteinuria in Non-Dialysis Chronic Kidney Disease Patients
    Hojs, Nina
    Bevc, Sebastjan
    Balon, Breda Pecovnik
    Hojs, Radovan
    Ekart, Robert
    THERAPEUTIC APHERESIS AND DIALYSIS, 2013, 17 (04) : 368 - 372
  • [44] Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease
    Webb, Nicholas J. A.
    Lerner, Gary
    Warady, Bradley A.
    Dell, Katherine M.
    Greenbaum, Larry A.
    Ariceta, Gema
    Hoppe, Bernd
    Linde, Peter
    Lee, Ho-Jin
    Eldred, Ann
    Dufek, Matthew B.
    PEDIATRIC NEPHROLOGY, 2017, 32 (07) : 1221 - 1232
  • [45] Cardiovascular treatment in chronic kidney disease
    Brandenburg, Vincent
    Saritas, Turgay
    Schirmer, Stephan H.
    Rogacev, Kyrill
    Heine, Gunnar Henrik
    HERZ, 2023, 48 (05) : 413 - 424
  • [46] Chronic kidney disease and cardiovascular risk
    O'Rourke, MF
    Safar, ME
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (07): : 791 - 791
  • [47] Chronic kidney disease and cardiovascular risk
    Yerram, Preethi
    Karuparthi, Poorna R.
    Hesemann, Laura
    Horst, Jennifer
    Whaley-Connell, Adam
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2007, 1 (03) : 178 - 184
  • [48] Chronic kidney disease and cardiovascular complications
    Luca Di Lullo
    Andrew House
    Antonio Gorini
    Alberto Santoboni
    Domenico Russo
    Claudio Ronco
    Heart Failure Reviews, 2015, 20 : 259 - 272
  • [49] Oral paricalcitol: expanding therapeutic options for pediatric chronic kidney disease patients
    Freundlich, Michael
    Abitbol, Carolyn L.
    PEDIATRIC NEPHROLOGY, 2017, 32 (07) : 1103 - 1108
  • [50] Chronic kidney disease and cardiovascular complications
    Di Lullo, Luca
    House, Andrew
    Gorini, Antonio
    Santoboni, Alberto
    Russo, Domenico
    Ronco, Claudio
    HEART FAILURE REVIEWS, 2015, 20 (03) : 259 - 272
12345